Companies›Healthcare›Healthcare›Pharmaceuticals & Biotechnology
NSE:AHCL

ANLON HEALTHCARE LIMITED

Healthcare › Pharmaceuticals & Biotechnology
₹24.36
at close · 27 Oct 2026
▼ 0.44 (-1.77%)

Latest filings

Next results: Thu, 29 Oct · Financial Results
  1. Anlon Healthcare schedules Q2 and H1 FY27 earnings call · Board & Shareholder Meetings
  2. Board meeting set to approve Q2 and half-year results · Results
  3. SDD Compliance Certificate for Quarter ended September 30, 2026 · Compliance
All filings ↓
Ask Nexa about ANLON HEALTHCARE LIMITED

Snapshot

What the business is, and whether it's a good one at a fair price.

AI · written from filings

Manufactures and sells pharmaceutical active ingredients, with a focus on pain management APIs. Runs contract development and manufacturing projects for global innovator drug companies, with 3 molecules currently under development for 2 such companies, and has filed 21 Drug Master Files to date. In Q1 FY27, acquired a 63.98% stake in Remember India Health Links to enter finished dosage formulations, bringing in 30+ formulation dossiers, and incorporated two new subsidiaries to build a presence in peptides/biosimilars and surgical implants/medical devices. Sells to pharmaceutical, nutraceutical, veterinary and personal care customers across 15+ countries and has begun diversifying into industrial and fine chemicals. Raw materials form the bulk of operating costs, with depreciation and employee costs making up smaller shares.

Operating scale
Drug Master Files filed
21 DMFs
Geographic reach
15+ countries
CDMO molecules in development
3 molecules for 2 global innovator companies
Formulation dossiers added
30+ dossiers (via Remember India Health Links acquisition)
Subsidiaries
Apiqo Organics, Bizotic Lifescience, Anlon Medicos, Anlon Medicare, Anlon Biologics
Materials as share of revenue
86.8% of revenueFY26
Who pays it
Pharmaceutical, nutraceutical, veterinary and personal care companies across 15+ countries, plus 2 global innovator drug companies for CDMO work.
Biggest cost
Raw materials, at 86.8% of revenue (FY26).
Kind of business
Pharmaceutical API manufacturer and CDMO player diversifying into formulations, biologics and medical devices.
Where it sits
NSE- and BSE-listed pharmaceutical API manufacturer (listed September 2025) with operations across 15+ countries and a CDMO business serving 2 global innovator companies.
Market Cap
₹1,295 Cr
P / E (TTM)
—
EV / EBITDA
—
Div Yield
—
Growth
—·
Revenue 5y CAGR
PAT — · EBITDA —
Quality
17.4%▲
ROCE (FY26)
ROE 11.4% · margin 27.8%
Leverage
0.17·
Debt / Equity · low
Net debt ₹39 Cr
Moves on a normal day
1.71%·
Median daily move
Last 267 sessions · the yardstick for filing-day moves
Where it sits among 185 Pharmaceuticals peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#18/158
P/B#118/163
ROCE#54/183
ROE#73/166
Debt / Equity#88/166
EBITDA margin#80/165

Scorecard

Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice

Strengths
Returns on capital 17.4%
#54 of 183 in Pharmaceuticals on the latest reported figures
Concerns
Heavy working capital — 371 days of cash tied up

Charts

How has the market priced it — with filings on the timeline?

AHCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from ANLON HEALTHCARE LIMITED's filed financials and exchange disclosures

What does ANLON HEALTHCARE LIMITED do?

ANLON HEALTHCARE LIMITED is a Pharmaceuticals & Biotechnology company listed on NSE and BSE, trading under the symbol AHCL.

Does ANLON HEALTHCARE LIMITED pay a dividend?

Not in the latest reported year — ANLON HEALTHCARE LIMITED's dividend payout for FY26 was nil.

Is ANLON HEALTHCARE LIMITED debt-free?

No. It reported borrowings of ₹44 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹39 Cr after cash. Debt stands at 0.17× equity. That is higher than 53% of its 166 Pharmaceuticals peers.

How much does the ANLON HEALTHCARE LIMITED share price move in a day?

On a typical session ANLON HEALTHCARE LIMITED moves 1.71% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.

When are ANLON HEALTHCARE LIMITED's next results?

Financial Results on Thu, 29 Oct. MarketPing alerts you on WhatsApp the moment the filing lands.

Where can I track ANLON HEALTHCARE LIMITED's announcements?

Every NSE and BSE filing by ANLON HEALTHCARE LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.